Similarly, in vivo studies demonstrated Bobcat339’s capacity to inhibit the growth of MSKPCa1 (Fig. 7e, f) and DU145, an LKB1-negative/AR-negative prostate cancer cell line (Fig. 7g, h). Here, AR is linked to prostate carcinoma.